Evidence map›Paper›PMID 37998784›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Evaluating the Potency of Selected Antibiotic Medications Dispensed in Community Pharmacies in Gwale, Kano, Nigeria.

Muhammad Dauda Mukhtar, Fatihu Ahmad Rufa'i, Abdurrahaman Umar Yola, Nafisa Ibrahim Babba, Daniel Baecker

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Muhammad Dauda MukhtarDepartment of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Bayero University Kano, Gwarzo Road, Kano PMB 3011, Nigeria.
Fatihu Ahmad Rufa'iKano Liaison Office, Nigerian Institute for Trypanosomiasis (and Onchocerciasis) Research, Surame Road, Kaduna PMB 2077, Nigeria.
Abdurrahaman Umar YolaDepartment of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Bayero University Kano, Gwarzo Road, Kano PMB 3011, Nigeria.
Nafisa Ibrahim BabbaDepartment of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Bayero University Kano, Gwarzo Road, Kano PMB 3011, Nigeria.
Daniel BaeckerDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Straße 2+4, 14195 Berlin, Germany.ORCID 0000-0002-1963-9838
Bayero University Kano · NGFreie Universität Berlin · DENigerian Institute for Trypanosomiasis Research · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worsening of antibiotic resistance is a multifactorial process. One aspect of this is the counterfeiting of antibiotic medications. This is supposed to be particularly high in developing countries, including Nigeria. Therefore, the potency of some antibiotic drugs dispensed in community pharmacies in Gwale, Kano, Nigeria, was investigated in this case study. Three products, each from different manufacturers, with the active ingredients of ceftriaxone, gentamicin, ciprofloxacin, and metronidazole, respectively, were included in this study. By means of a disc-diffusion assay, the effect against the typed strains

Indexed as

antibioticsClostridium tetanicounterfeit medicationsdisc-diffusion assaydrug qualityEscherichia coliNigeriaresistanceStaphylococcus aureus

Identifiers

PMID37998784
PMCPMC10668698
OpenAlexW4388041768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.